<DOC>
	<DOCNO>NCT02082769</DOCNO>
	<brief_summary>The purpose study compare febuxostat allopurinol subject gout .</brief_summary>
	<brief_title>Safety Efficacy Oral Febuxostat Subjects With Gout</brief_title>
	<detailed_description>A randomized , double-blind , multicenter , allopurinol-controlled parallel-assigned study compare 40 mg , 80 mg febuxostat , allopurinol 300 mg subject gout . Subjects receive treatment 24 week .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<criteria>Hyperuricemia ( serum urate ≥8.0 mg/dL ) gout Chinese Rheumatism Association Criteria ; Renal function define serum creatinine level &lt; 2.0 mg/dL creatinine clearance &gt; 20 milliliter per minute ( mL/min ) Cockcroft Gault formula ; No gout flare 2 week beforehand 2week screening period . Pregnancy lactation ; Concurrent therapy urate lower agent , azathioprine , 6mercaptopurine , thiazide diuretic , medication contain aspirin ( &gt; 325 mg ) salicylates ; Body Mass Index ( BMI ) &gt; 50 kilogram per meter² ( kg/m² ) ; A history active liver disease , hepatic dysfunction ; A history bronchial asthma ; A history renal calculus thyroid disease ; Secondary gout Joint disease induce rheumatoid arthritis , psoriatic arthritis bone tumor ; Intolerance allopurinol Ibuprofen ; Alcohol intake ≥ 14 drinks/week ; Clinically significant medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Gout</keyword>
	<keyword>Uric Acid</keyword>
	<keyword>Xanthine oxidase</keyword>
	<keyword>Febuxostat</keyword>
</DOC>